synthetic adeno-associated viral vector-based ASAH1 gene therapy (Gromit Therapeutics/Icahn School of Medicine/Hebrew University of Jerusalem)
N/A
Report date: 2025/01/26 15:53:58
Base Information
Drug Namesynthetic adeno-associated viral vector-based ASAH1 gene therapy (Gromit Therapeutics/Icahn School of Medicine/Hebrew University of Jerusalem)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A
Develop Information
Active CompaniesGromit Therapeutics IncIcahn School Of Medicine At Mount SinaiThe Hebrew University Of Jerusalem
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A